Skip to content

Effect of an Iranian Toothpaste on Decrease of Decay

Comparison of an Iranian Toothpaste with a Common Toothpaste on Plaque Index of Children between 9-12 years old

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015112925279N1
Enrollment
26
Registered
2016-01-01
Start date
2015-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental caries. Dental caries, unspecified

Interventions

Intervention 1: The control group use Complete Crest toothpaste containing anti plaque components and fluoride produced by Procter and Gamble factory in Germany (2 times a day for 2 minutes). Interven
Prevention
The control group use Complete Crest toothpaste containing anti plaque components and fluoride produced by Procter and Gamble factory in Germany (2 times a day for 2 minutes).
The intervention group use Bath toothpaste containing anti plaque agents and fluoride produced by Iran Avandfar in Iran (2 times a day for 2 minutes).

Sponsors

Vice chancellor for research, Guilan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
9 Years to 12 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Good oral hygiene; Daily use of fluoride toothpaste; At least 5 teeth per quadrant Exclusion criteria: A systemic disease affecting saliva production; Antibiotics in the past month; A sensitivity to the ingredients in toothpaste; Have active decay or crown; Have an orthodontic appliance; Having periodontal pockets deeper than 3 mm; Tooth exfoliation during the wash out period

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Dental plaque. Timepoint: 1 and 3 weeks after intervention. Method of measurement: Turesky Index.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyedeh Maryam Seyed Hosseini

Faculty of dentistry, Guilan University of Medical Sciences

m.hosseini285@gmail.com+98 13 3348 6406

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026